For many emerging medical device companies, obtaining FDA clearance or other regulatory approval is viewed as a major milestone. While bringing a product to market is a significant achievement, it also introduces a new category of exposure that many founders and investors underestimate: intellectual property litigation risk.
One important question companies should consider is:
Is Your Company Financially Prepared to Respond to an Intellectual Property Infringement Claim?
As a medical device company begins marketing a new product, it may attract immediate attention from larger, established competitors. In some cases, those competitors may allege that the product infringes on existing patents, intellectual property, or proprietary technology.
Whether the claim has merit or not, the financial impact can be significant.
The Cost of Defending Intellectual Property Claims
Intellectual property disputes within the medical device and life sciences sectors are often complex, time-consuming, and expensive. Legal defense costs alone can quickly exceed $1 million, particularly when larger industry players are involved.
For emerging companies, the challenge is not only the legal exposure itself, but also the financial pressure associated with responding effectively while continuing to operate and grow the business.
A poorly prepared response can:
- Delay commercialization efforts
- Disrupt fundraising activities
- Impact investor confidence
- Create operational strain
- Increase settlement pressure
Growth Creates Visibility — and Risk
As companies gain traction in the marketplace, they also become more visible to competitors. Regulatory approval and commercial launch often represent the point at which competitive scrutiny increases significantly.
This is especially true in:
- Medical devices
- Diagnostics
- Digital health
- Biotech and life sciences
- AI-driven healthcare technologies
Companies entering competitive markets should proactively evaluate not only product development and commercialization strategies, but also their legal, insurance, and financial preparedness.
Risk Management and Insurance Considerations
Emerging medical device companies should carefully review:
- Intellectual property exposure
- Directors & Officers (D&O) liability protections
- Errors & Omissions (E&O) coverage
- Cyber and technology liability policies
- Litigation funding preparedness
- Contractual protections and indemnification provisions
Understanding where coverage exists—and where it does not—is critical.
Protect Your Company Before a Claim Happens
For founders, boards, and investors, preparing for intellectual property disputes should be part of the broader growth strategy—not an afterthought after a claim is filed.
If your company is preparing to commercialize a medical device, diagnostic platform, or healthcare technology, I’d be happy to discuss ways to strengthen your insurance and risk management strategy, identify potential gaps, and help your company avoid costly surprises as it grows.